| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |